{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:32:15Z","timestamp":1773289935792,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.humimm.2014.01.010","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T12:31:15Z","timestamp":1391171475000},"page":"338-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization"],"prefix":"10.1016","volume":"75","author":[{"given":"Alexandre","family":"Bosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Eguia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Mrowiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Boix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Campillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Moya-Quiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Minguela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Jimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda R.","family":"\u00c1lvarez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2014.01.010_b0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfh527","article-title":"Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRA\u2122, ELISA and CDC vs luminex screening","volume":"20","author":"Muro","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.humimm.2014.01.010_b0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.trim.2010.12.003","article-title":"Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants","volume":"24","author":"Duquesnoy","year":"2011","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.humimm.2014.01.010_b0015","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.transproceed.2011.09.023","article-title":"Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome","volume":"43","author":"Gilbert","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.humimm.2014.01.010_b0020","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1600-6143.2011.03584.x","article-title":"Anti-Cw donor-specific alloantibodies can lead to positive flow cytometry crossmatch and irreversible acute antibody-mediated rejection","volume":"11","author":"Bachelet","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.humimm.2014.01.010_b0025","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1111\/j.1432-2277.2011.01408.x","article-title":"Transplant glomerulopathy and rapid allograft loss in the presence of HLA-Cw7 antibodies","volume":"25","author":"Rogers","year":"2012","journal-title":"Transplant Int"},{"key":"10.1016\/j.humimm.2014.01.010_b0030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.humimm.2012.07.320","article-title":"Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients","volume":"73","author":"Ling","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2014.01.010_b0035","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.humimm.2010.05.018","article-title":"Specific \u201cintra-allele\u201d (IA) and \u201cintra-broad antigen\u201d (IBA) HLA alloantibodies in kidney graft transplantation","volume":"71","author":"Muro","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2014.01.010_b0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.humimm.2012.02.020","article-title":"Low median fluorescence intensity (MFI) could be a non-safety concept of immunological risk evaluation in patients with shared molecular eplets in kidney transplantation","volume":"73","author":"Bosch","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2014.01.010_b0045","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ndt\/gfr429","article-title":"Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation","volume":"27","author":"Caro","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.humimm.2014.01.010_b0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0039.2010.01608.x","article-title":"Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations?","volume":"77","author":"Zoet","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2014.01.010_b0055","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/01.TP.0000120385.03278.28","article-title":"The number of aminoacid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens","volume":"77","author":"Dankers","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2014.01.010_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1744-313X.2011.01042.x","article-title":"The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity","volume":"39","author":"Duquesnoy","year":"2012","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.humimm.2014.01.010_b0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1399-0039.2011.01646.x","article-title":"Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications","volume":"77","author":"Duquesnoy","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2014.01.010_b0070","first-page":"116","article-title":"Has solid phase testing for alloantibody moved us ahead?","volume":"33","author":"Adams","year":"2009","journal-title":"ASHI Q"},{"key":"10.1016\/j.humimm.2014.01.010_b0075","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","article-title":"Summary of FDA antibody-mediated rejection workshop","volume":"11","author":"Archdeacon","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.humimm.2014.01.010_b0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885914000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885914000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T01:21:34Z","timestamp":1538875294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885914000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0198885914000184"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2014.01.010","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2014.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}